Skip to main content
HR 5548 115th Congress House

Water, Cosmetics, and Unwanted Pharmaceuticals Study Act

Official title: To require the Administrator of the Environmental Protection Agency to conduct a study on the presence of pharmaceuticals and personal care products in sources of drinking water.

Introduced: April 18, 2018 Introduced by: Schakowsky, Janice D. Democratic · Illinois See on congress.gov
Environmental Protection Drug safety, medical device, and laboratory regulationEnvironmental assessment, monitoring, researchGovernment studies and investigationsHazardous wastes and toxic substances
More subjectsShow fewer subjects
Water qualityWater use and supply
Sign in to write a letter Sign in to watch
This bill died when the 115th Congress ended
It never became law before the 115th Congress (2017–2018) adjourned, and bills don't carry over to the next Congress. It would have to be reintroduced. You can still save it for reference, but it won't receive updates.
 Everywhere this bill has been 2 steps
Introduced
In committee
Reported out
Passed House
Passed Senate
To President
Became law
Apr 18, 2018
Referred to the House Committee on Energy and Commerce.
Apr 18, 2018
Introduced in House
 Ask about this bill AI · grounded in the bill text

Have a question about what this bill does? Ask in plain English; the answer is drawn from the bill's actual text and official record, and it'll tell you when something isn't in the text rather than guess.

AI answers can be imperfect; always confirm against the full bill text.

 Latest action April 18, 2018

Referred to the House Committee on Energy and Commerce.

 Plain-English summary Congressional Research Service

Water, Cosmetics, and Unwanted Pharmaceuticals Study Act

This bill amends the Safe Drinking Water Act to require the Environmental Protection Agency to carry out a study on the presence of pharmaceuticals and personal care products in sources of drinking water. The study must identify:

  • pharmaceuticals and personal care products that have been detected in the sources;
  • the levels at which the pharmaceuticals and products have been detected;
  • the origins of pharmaceuticals and products found in drinking water;
  • the effects of the pharmaceuticals and products on humans, the environment, and the safety of drinking water; and
  • methods to control, limit, treat, or prevent the presence of pharmaceuticals and products in sources of drinking water.
 Related & companion bills 1
  • HR 6818 Related bill Clean Water Infrastructure Act
 Bill text 1 version

Source documents hosted by congress.gov.

 Committees of jurisdiction 1
Cite this page click to expand
APA
U.S. Congress. (2026). H.R. 5548: Water, Cosmetics, and Unwanted Pharmaceuticals Study Act. 115th Congress. Open America. https://openamerica.io/bill/115-HR-5548/
MLA
"H.R. 5548: Water, Cosmetics, and Unwanted Pharmaceuticals Study Act." 115th Congress, 2026, Open America, https://openamerica.io/bill/115-HR-5548/.
Bluebook (legal)
H.R. 5548, 115th Cong. (2026), https://openamerica.io/bill/115-HR-5548/.
Markdown link
[H.R. 5548: Water, Cosmetics, and Unwanted Pharmaceuticals Study Act](https://openamerica.io/bill/115-HR-5548/)
Report a problem